20.000
+0,00%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -4.4% | +12.1% | 1 / 3 | -0.9% | +4.48 pp | -0.52 pp | +13.1% | 0.39 | 8.03 | 119 | −0,9% | 23,6 | −3,4% | 8.03 | 13.24 | −39,4% |
| Pts | 0 | 0 | 4 | 0 | 12 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 20.000 (close price on 2026-10-19)EPS (TTM): 2.491
Financial charts
1.Revenue & growth
VND bn119Q2/26
1.Revenue & growth
VND bn119Q2/26
2.Profit & growth
VND bn19,6Q2/26
3.Profit mix (Penman)
VND bn107Q2/26
4.Margins & cost structure
%49.9%Q2/26
5.Returns & cash cycle
% · days12.9%Q2/26
6.Earnings quality & cash
VND bn102Q2/26
7.Asset structure
VND bn972Q2/26
8.Funding & debt health
VND bn · times972Q2/26
9.Revenue backlog
VND bn0,62Q2/26
10.Valuation
times · %8,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %700Q2/26
Adjusted EPS growth, latest quarter
-4.4%
Average adjusted EPS growth, 3 quarters
12.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26